Navigation Links
SurgLine International, Inc. to Expand its Trauma Product Line With Completion of Acquisition
Date:5/17/2012

WEST PALM BEACH, Fla., May 17, 2012 /PRNewswire/ -- SurgLine International, Inc. (SGLN.PK)

Thomas Toland, CEO of SGLN and SurgLine, Inc. ("SurgLine") stated that the Company has acquired Eden Surgical Technologies, LLC., ("Eden") a Texas Limited Liability Company.  Eden is a distributor of trauma products with extensive products focused on this highly profitable sector.

"We are pleased to announce today that we have acquired Eden pursuant to a Share Exchange Agreement (the "Agreement") in exchange of 50 million shares of restricted common stock of SGLN." Toland went on to say, "the acquisition of Eden will substantially expand our line of trauma products while providing the company with pricing which we believe will give us a competitive advantage in the marketplace. We will have immediate access to products that are crucial to our acute care hospital clients in particular. These products include both stainless steel and titanium offerings."

"As we continue to meet the potential demand to significantly lower the cost of trauma related hardware for our clients, this transaction will provide the Company a very compelling and competitive line up of products to achieve our goal of 'More Savings for Your Healthcare Dollar' with additional focus on our trauma hardware line to complement our spinal implant line."

About SurgLine, Inc.

SurgLine (www.surgline.com) sources and distributes high quality FDA approved medical and surgical products at discount prices, thereby reducing or eliminating the historical brand premium paid by healthcare providers including acute care hospitals, surgery centers, surgical hospital, self-insured employers and insurance companies. SurgLine offers high quality medical and surgical supplies and products at substantial savings utilizing stocking distributors and institutional buyers by sourcing products globally without the historical brand premium and industry markup.

About SurgLine International, Inc.

SurgLine International, Inc. is a holding company that in addition to SurgLine, wholly owns Nuvo Solar Energy, Inc., a development stage company that owns unique patent pending solar and photovoltaic related technology.  The Company is also seeking other business opportunities.

This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on the Company's current expectations as to future events. However, the forward-looking events and circumstances discussed in this press release might not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements.

For Further Information Contact:
Thomas Toland
949-698-8485


'/>"/>
SOURCE SurgLine International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SurgLine International, Inc. Chief Executive Officer, Thomas Toland, Exclusive Interview on Stock Traders Talk Radio
2. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
3. SurgLine International, Inc. Update On New Revenues
4. SurgLine International, Inc. Announces Over 1 Billion Shares Returned to Company
5. SurgLine International, Inc. Update to Shareholders on Revenue Pipeline and Organizational Changes
6. China Nuvo Solar Energy, Inc. Completes Name Change to SurgLine International, Inc.
7. China Nuvo Solar Energy, Inc./SurgLine Announces New Mobile Marketing Campaign
8. China Nuvo Solar, Inc. Announces Corporate Name Change to SurgLine International, Inc.
9. China Nuvo Solar Completes Acquisition of SurgLine
10. China Nuvo Solar Target Acquisition SurgLine Reports on Marketing Progress
11. China Nuvo Solar Target Acquisition SurgLine Updates OptiMedical Corp.s Sales Forecast in Excess of $10,000,000
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)...  Just 18 months after its February 2016 launch, ... the appointment of three new senior people to its ... Jones-Phillips and James Wright bring decades ... Tammy Wynne joins as Director, ... She has over ten years, experience in global market ...
(Date:8/31/2017)... PM360,s annual Innovations Issue, published in ... innovations happening across the industry. Established six years ago, ... providing a comprehensive look at the newest and most ... innovative companies, startups, divisions, products, services, and strategies from ... "Everyone in this industry wants to do better—in all ...
Breaking Medicine Technology:
(Date:9/20/2017)... , ... September 20, 2017 , ... Doctors on Liens ... their qualified network of medical professionals working on a personal injury lien basis. Founded ... Surgery Inc brings these esteemed doctors’ vast experience with orthopedic injuries to patients in ...
(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer True ... edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes Convention ... speakers — representing such thought-leading companies as JP Morgan Chase, GE Digital, ...
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy Group is proud ... The Guard®, has helped another long-time client pass their Department of Health and ... the law. , Thanks to the help of the Compliancy Group's Audit Response ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... social campaign, “Humans With Vaginas.” The goal is to ignite conversation via social ... personal care products. The brand has declared September “Humans with Vaginas” month, releasing ...
(Date:9/20/2017)... ... September 20, 2017 , ... Medicare doesn’t ... risk of price gouging for their prescription drugs, according to a new comparison ... isn’t negotiating on our behalf, there’s no consistency in drug pricing among drug ...
Breaking Medicine News(10 mins):